Equity & Derivatives

Board Meetings

Date Heading Details
25-Nov-2020 Ambassador IntraHold inter alia, to consider and approve the following: ? Appointment of Mr. Sanjay Kumar as an Independent Director and Ms. Smailika as a Woman Independent Director. ? Resignation of Mr. Nirmalkumar Ramnath Tiwari, Independent Director and Mrs. Anjali Ajay Mehra, Woman Independent Director. ? Appointment of Mr. Rahul Shyamlal Gupta (ICSI Membership No.: A53172) as a Company Secretary and Compliance Officer of the Company. ? Any other matter with the permission of Chairman.
25-Nov-2020 Binani Inds Audited Results
25-Nov-2020 Coffee Day Enter. Quarterly Results & Audited Results
25-Nov-2020 Continental Chem inter alia, to consider the below mentioned matters; A) To consider, discuss and approve the Notice for calling 35th Annual General Meeting of the Company for the Financial Year ended on 31? March, 2020; B) To Consider, discuss and approve the appointment of Scrutinizer for scrutinizing the process in the 35th Annual General Meeting of the Company;; C) To consider, discuss and approve the Board Report of the Company for the Financial Year ended on 31st March, 2020; D) To consider, discuss and approve the Book Closure Period as per Section 91 of Companies Act, 2013 and Regulation 42 of SEBI (LODR), Regulations 2015 for the purpose of Annual General Meeting of the Company; E) Any other matter with the permission of chair.
25-Nov-2020 Dewan Hsg Fin. Corp. Quarterly Results
25-Nov-2020 Elegant Flori. &Agro Inter alia, to consider and approve : 1. To consider and appoint Mr. Ashokkumar Jaikran Banka (holding DIN 01640907) as an Additional Director ? Independent on the Board of Directors of the Company; 2. Any other business with the permission of the Chair
25-Nov-2020 Gopala Polyplast Reduction of Capital
25-Nov-2020 Ledo Tea Voluntary Delisting of Shares
25-Nov-2020 Mahip Industries Half Yearly Results (Revised)
25-Nov-2020 Manipal Fin Corp Inter alia, to consider and approve convening the 37th AGM, to fix book closure, reclassification of exiting authorised capital, issue of NCRP shares to the existing shareholders on preferential allotment basis.